SCHEMBL15868165

SCHEMBL15868165

Cc1ccc(-c2ccncc2)cc1-c1cc(C(=O)O)nn1C

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 2/20 0.43
▸ PPARA Q07869 2/20 0.43
▸ ESRRA P11474 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ MARS1 P56192 2/20 0.41
▸ PLA2G10 O15496 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ APOBEC3A P31941 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ PPP1CA P62136 1/20 0.38
▸ RPA1 P27694 4/20 0.37
▸ CHUK O15111 1/20 0.37
▸ GSK3B P49841 1/20 0.36
▸ RARB P10826 1/20 0.36
▸ RARG P13631 1/20 0.36
▸ RXRA P19793 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15868144 0.86 NR4A2 (0.46) PPARGPPARAESRRAPLA2G10SMN1; SMN2
SCHEMBL15868129 0.84 FAAH (0.47) PPARGPPARAALDH1A1
SCHEMBL20656279 0.82 RPA1 (0.47) PPARGPPARAALDH1A1MARS1KDM4E
SCHEMBL15862193 0.81 ALDH1A1 (0.45) ALDH1A1MARS1PLA2G10KDM4EPOLB
SCHEMBL15868125 0.80 PTGDR2 (0.42) ESRRAALDH1A1PLA2G10KDM4EPOLB
SCHEMBL15868133 0.80 BRD4 (0.43) ESRRAALDH1A1PLA2G10KDM4EPOLB
SCHEMBL15861533 0.79 IL2 (0.43) PPARGPPARAKDM4ESMN1; SMN2
SCHEMBL15869831 0.79 SMN1; SMN2 (0.47) ALDH1A1MARS1SMN1; SMN2PPP1CARPA1
SCHEMBL15861655 0.79 F10 (0.41) PPARGPPARAKDM4ESMN1; SMN2
SCHEMBL15869840 0.75 CHRNB2 (0.42) ESRRAALDH1A1MARS1PLA2G10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9206136-B2 Pyrazolyl-based carboxamides I Grünenthal GmbH (DE) 2015-12-08 — — US disclosed
US-9206136-B2 Pyrazolyl-based carboxamides I Grünenthal GmbH (DE) 2015-12-08 — — US disclosed
WO-2014108337-A1 PYRAZOLYL-BASED CARBOXAMIDES I AS CRAC CHANNEL INHIBITORS Grünenthal GmbH (DE) 2014-07-17 — — WO disclosed
US-20140194443-A1 Pyrazolyl-Based Carboxamides I Grünenthal GmbH (DE) 2014-07-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140194443-A1 Pyrazolyl-Based Carboxamides I AADAC, HDAC3, NLRP3 PPARG 43/4885PPARA 62/4885ESRRA 1057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback